DeepValuesResearch
CompaniesInsightsMarketGurusPrinciplesBuffett ArchivePersonal FinanceBusiness NotesLatestBullish stocksNeutral stocksBearish stocksSectorsMost covered For agents & developers

AHealthcare · Diagnostics & Research

Agilent Technologies, Inc.

DeepValues Research covers Agilent Technologies (A) with 9 research reports since May 22, 2026. The latest Deep Value Intelligence report (Sep 11, 2026) ends with a Neutral stance (2.83/5), with the stock at $143 against a headline intrinsic value of $66. Sector: Healthcare · Diagnostics & Research. Neutral since Sep 11, 2026 (previously Bearish); 4 stance changes across 9 scored reports since May 22, 2026.

Latest stanceNeutral2.83
Reports9since May 22, 2026
Latest reportEN

Stance history

Neutral since Sep 11, 2026 (previously Bearish); 4 stance changes across 9 scored reports since May 22, 2026.

  1. Neutral3.02
  2. Neutral2.92
  3. Neutral3.02
  4. Neutral3.02
  5. Bearish2.92
  6. Bearish2.83
  7. Neutral2.83
  8. Bearish2.83
  9. Neutral2.83

Research timeline

  1. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (2.83/5) on Agilent Technologies (A), Sep 11, 2026. Price $143 vs intrinsic value $66. Agilent (A) is an elite, wide-moat compounder generating…

    Neutral2.83EN34 min

  2. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Bearish (2.83/5) on Agilent Technologies (A), Aug 28, 2026. Price $158 vs intrinsic value $71. Agilent Technologies (A) presents a textbook clash between…

    Bearish2.83EN33 min

  3. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (2.83/5) on Agilent Technologies (A), Aug 14, 2026. Price $149 vs intrinsic value $71. Agilent (A) is an elite, wide-moat compounder with…

    Neutral2.83EN34 min

  4. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Bearish (2.83/5) on Agilent Technologies (A), Jul 31, 2026. Price $139 vs intrinsic value $71. This snapshot anchors the most recent reported quarter…

    Bearish2.83EN33 min

  5. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Bearish (2.92/5) on Agilent Technologies (A), Jul 17, 2026. Price $136. This snapshot anchors the most recent reported quarter before the narrative…

    Bearish2.92EN38 min

  6. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (3.02/5) on Agilent Technologies (A), Jul 3, 2026. Price $131. This snapshot anchors the most recent reported quarter before the narrative…

    Neutral3.02EN32 min

  7. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (3.02/5) on Agilent Technologies (A), Jun 19, 2026. Price $127. This snapshot anchors the most recent reported quarter before the narrative…

    Neutral3.02EN33 min

  8. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (2.92/5) on Agilent Technologies (A), Jun 5, 2026. Price $138. This snapshot anchors the most recent reported quarter before the narrative…

    Neutral2.92EN35 min

  9. Deep Value Intelligence

    Agilent Technologies, Inc. (A) Deep Value Intelligence Report

    Neutral (3.02/5) on Agilent Technologies (A), May 22, 2026. Price $115. This snapshot anchors the most recent reported quarter before the narrative…

    Neutral3.02EN36 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
AAgilent Technologies Diagnostics & Research Neutral2.83 $143 · $66 9
JNJJohnson & Johnson Drug Manufacturers - General Neutral3.08 $264 · $184 3
GRDN Medical Care Facilities Bearish3.16 $40 · $14 1
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1
ABTAbbott Laboratories Medical Devices Neutral3.05 $103 · $59 9
ABBVAbbVie Drug Manufacturers - General Bullish2.35 $257 · $151 11

Charts from the latest report

Open report
Fundamentals Key MetricsFundamentals Key MetricsFundamentals Key MetricsYear Financial Metrics (Profitability)Year Financial Metrics (Health)Revenue BreakdownLatest Earnings SnapshotCurrent vs. 10-Year Historical Average ComparisonBuffett-Style Owner Earnings DCF ValuationBuffett-Style Owner Earnings DCF ValuationBuffett-Style Owner Earnings DCF Valuation